{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:31:15Z","timestamp":1793323875957,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Natural Science Foundation of Fujian Province","award":["2017J01378"],"award-info":[{"award-number":["2017J01378"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10238-021-00707-x","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T13:02:53Z","timestamp":1618232573000},"page":"611-619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5343-481X","authenticated-orcid":false,"given":"Yanli","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinggui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaJia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longcan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"issue":"2","key":"707_CR1","first-page":"25","volume":"23","author":"MM Hargraves","year":"1948","unstructured":"Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements the tart cell and the L.E. cell. Proc Staff Meet Mayo Clinic. 1948;23(2):25\u20138.","journal-title":"Proc Staff Meet Mayo Clinic"},{"key":"707_CR2","unstructured":"Rosken GHJ, van Beek AA, Bakker-Jonges LE, Schreurs MWJ. Antinuclear antibodies in systemic autoimmune disease. Ned Tijdschr Geneeskd 2020, 164."},{"key":"707_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/814748","author":"RC Oliveira","year":"2015","unstructured":"Oliveira RC, Oliveira IS, Santiago MB, Sousa Atta ML, Atta AM. High avidity dsDNA Autoantibodies in Brazilian women with systemic lupus erythematosus: correlation with active disease and renal dysfunction. J Immunol Res. 2015. https:\/\/doi.org\/10.1155\/2015\/814748.","journal-title":"J Immunol Res"},{"issue":"2","key":"707_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clim.2008.03.516","volume":"128","author":"HA Kim","year":"2008","unstructured":"Kim HA, Jeon JY, Choi GS, et al. The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans. Clin Immunol. 2008;128(2):277\u201383.","journal-title":"Clin Immunol"},{"issue":"3","key":"707_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1128\/CMR.4.3.256","volume":"4","author":"MJ Fritzler","year":"1991","unstructured":"Fritzler MJ, Salazar M. Diversity and origin of rheumatologic autoantibodies. Clin Microbiol Rev. 1991;4(3):256\u201369.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"707_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10067-019-04775-z","volume":"39","author":"YQ Bao","year":"2020","unstructured":"Bao YQ, Wang JP, Dai ZW, et al. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis. Clin Rheumatol. 2020;39(1):281\u201390.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"707_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00403-018-1836-6","volume":"310","author":"A Niederkorn","year":"2018","unstructured":"Niederkorn A, Fruhauf J, Schwantzer G, et al. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study. Arch Dermatol Res. 2018;310(6):485\u201393.","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"707_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3899\/jrheum.090450","volume":"37","author":"HT Lee","year":"2010","unstructured":"Lee HT, Shiao YM, Wu TH, et al. Serum BLC\/CXCL13 concentrations and renal expression of CXCL13\/CXCR5 in patients with systemic lupus erythematosus and lupus Nephritis. J Rheumatol. 2010;37(1):45\u201352.","journal-title":"J Rheumatol"},{"issue":"12","key":"707_CR9","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1093\/ndt\/gfp343","volume":"24","author":"L Schiffer","year":"2009","unstructured":"Schiffer L, K\u00fcmpers P, Davalos-Misslitz AM, et al. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant. 2009;24(12):3708\u201312.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"707_CR10","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.4049\/jimmunol.180.7.5130","volume":"180","author":"F Barone","year":"2008","unstructured":"Barone F, Bombardieri M, Rosado MM, et al. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren\u2019s syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol. 2008;180(7):5130\u201340.","journal-title":"J Immunol"},{"issue":"9","key":"707_CR11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"707_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630\u201340.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"707_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"707_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271\u20137.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"707_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0961203308100481","volume":"18","author":"C Gordon","year":"2009","unstructured":"Gordon C, Jayne D, Pusey C, et al. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus. 2009;18(3):257\u201363.","journal-title":"Lupus"},{"key":"707_CR16","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s10067-020-05040-4","volume":"39","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Lin Y, Wang X, et al. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus. Clin Rheumatol. 2020;39:2619\u201329.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"707_CR17","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"707_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1186\/s40064-016-2462-4","volume":"5","author":"Y-L Zeng","year":"2016","unstructured":"Zeng Y-L, Lin Y-Q, Zhang N-N, et al. CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients. Springerplus. 2016;5:743\u201351.","journal-title":"Springerplus"},{"key":"707_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/0961203321995242","author":"YZ Yanli Zeng","year":"2021","unstructured":"Yanli Zeng YZ, Chen Qinggui, Huang Qinghe, Lin Yiqiang, Wang Xuelian, Wang Jiajia, Jiang Longcan, Xiao Yun. Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus. Lupus. 2021. https:\/\/doi.org\/10.1177\/0961203321995242.","journal-title":"Lupus"},{"issue":"8","key":"707_CR20","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/art.23667","volume":"58","author":"I Rioja","year":"2008","unstructured":"Rioja I, Hughes FJ, Sharp CH, et al. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Arthritis Rheum. 2008;58(8):2257\u201367.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"707_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10875-009-9325-5","volume":"30","author":"CK Wong","year":"2010","unstructured":"Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol. 2010;30(1):45\u201352.","journal-title":"J Clin Immunol"},{"issue":"7","key":"707_CR22","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/1521-4141(200207)32:7<1881::AID-IMMU1881>3.0.CO;2-Z","volume":"32","author":"S Ishikawa","year":"2002","unstructured":"Ishikawa S, Nagai S, Sato T, et al. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC\/CXCL13-producing DC. Eur J Immunol. 2002;32(7):1881\u20137.","journal-title":"Eur J Immunol"},{"issue":"5","key":"707_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/0961203310383301","volume":"20","author":"L Schiffer","year":"2011","unstructured":"Schiffer L, Kielstein JT, Haubitz M, et al. Elevation of serum CXCL13 in SLE as well as in sepsis. Lupus. 2011;20(5):507\u201311.","journal-title":"Lupus"},{"key":"707_CR24","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.2741\/2927","volume":"13","author":"O Kulkarni","year":"2008","unstructured":"Kulkarni O, Anders HJ. Chemokines in lupus nephritis. Front Biosci. 2008;13:3312\u201320.","journal-title":"Front Biosci"},{"issue":"12","key":"707_CR25","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1172\/JCI42213","volume":"120","author":"K Moreth","year":"2010","unstructured":"Moreth K, Brodbeck R, Babelova A, et al. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest. 2010;120(12):4251\u201372.","journal-title":"J Clin Invest"},{"issue":"5","key":"707_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13075-014-0434-z","volume":"16","author":"SR Greisen","year":"2014","unstructured":"Greisen SR, Schelde KK, Rasmussen TK, et al. CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic \u201cwindow of opportunity.\u201d Arthritis Res Ther. 2014;16(5):434\u201343.","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-021-00707-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T11:22:13Z","timestamp":1633951333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-021-00707-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1007\/s10238-021-00707-x","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"19 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of insert"}},{"value":"The study was approved by the Institutional Ethics Committee of Zhongshan Hospital, Medical College Xiamen University and conforms to the ethical guidelines of the Declaration of HELSINKI. Requirement for individual patient consent forms was waived due to the retrospective, observational nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}